We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04646356
Recruitment Status : Recruiting
First Posted : November 27, 2020
Last Update Posted : November 14, 2022
Sponsor:
Collaborator:
United States Department of Defense
Information provided by (Responsible Party):
Unity Health Toronto

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2023
Estimated Study Completion Date : September 2024